Novo Nordisk’s once-weekly insulin supersedes its once-daily counterparts

Submitted by admin on June 26, 2023 - 9:54am

Source:

Clinical Trials Arena

News Tags:

Headline:

snippet:

Phase IIIa clinical trials reported more patients achieving target HbA1c with Novo Nordisk’s insulin compared to its once-daily counterparts.

Search form